Iradier

Drospirenone, the active ingredient in Iradier, is a combined estrogen‑progestogen oral contraceptive presented as a tablet for oral use. Together with ethinylestradiol, it works to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus. The formulation follows European Union standards for quality and safety.

GNH USA supplies Iradier as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iradier, a combined estrogen‑progestogen oral contraceptive, is used in the hormonal regulation pathway to prevent unintended pregnancy. - Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing potential. - Management of dysmenorrhea: reduces menstrual pain and cramping. - Regulation of menstrual cycles: helps achieve predictable monthly bleeding. - Treatment of premenstrual dysphoric disorder: alleviates mood and physical symptoms associated with the luteal phase.

Iradier may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: discomfort or swelling of the breasts. - Headache: occasional throbbing or tension‑type pain. - Weight gain: modest increase in body weight. - Mood changes: irritability or emotional fluctuations. - Spotting or breakthrough bleeding: irregular vaginal bleeding.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Arterial thrombosis: clot formation in arteries leading to stroke or heart attack. - Hypertension: significant rise in blood pressure. - Liver dysfunction: abnormal liver enzyme levels or jaundice. - Gallbladder disease: inflammation or stones. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before initiating Iradier, clinicians should consider several safety aspects. - Assess thrombotic risk: evaluate personal or family history of clotting disorders. - Screen for hypertension: monitor blood pressure prior to and during therapy. - Avoid smoking: especially in women over 35 years of age. - Evaluate liver function: contraindicated in severe hepatic disease. - Confirm non‑pregnancy: perform a pregnancy test before starting. - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Iradier can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Strong enzyme inducers (e.g., rifampin, carbamazepine): reduce contraceptive efficacy. - Anticoagulants (e.g., warfarin): may increase risk of thrombosis. - Certain antifungals (e.g., ketoconazole): elevate hormone levels and risk of side effects.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracycline: may slightly diminish contraceptive effect. - Herbal supplements like St. John's wort: can lower plasma concentrations. - Diuretics: may enhance potassium loss due to drospirenone’s antimineralocorticoid activity.